JH

Julien Hadoux

Université Paris-Sud Faculté de Médecine, Université Paris Descartes Faculté de Médecine, Université Paris Diderot

Research areas: Medicine · Surgery · Thyroid Cancer Diagnosis and Treatment · Thyroid and Parathyroid Surgery · Neuroendocrine Tumor Research Advances

ORCID iD 0000-0002-1276-3289
Follow

About

Julien Hadoux is a medical oncologist with a PhD in oncology. He is the head of the endocrine tumor board at Gustave Roussy cancer center, Villejuif, France.
He is co-coordinator of the French national network on endocrine cancer, ENDOCAN and member of the Groupe d’étude des tumeurs endocrine (GTE, French NET group).
His main long-term research interests focus on endocrine tumors from a clinical and translational point of view. He is investigator in clinical trials focusing on endocrine tumors and has authored or coauthored more than 150 articles and book chapters in the field

Employment

Employment history is unavailable.

Education

  • Université Paris-Sud Faculté de Médecine PhD
    2012 - 2016
  • Université Paris Descartes Faculté de Médecine MD in medical oncology
    2007 - 2012
  • Université Paris Diderot Master 2
    2003 - 2004
  • Ecole Normale Supérieure Département de Biologie master of science
    2002 - 2007

Projects & Funding

  • PRODIGE 113 (FFCD 2314) – REWENEC – 01 STUDY Institut National Du Cancer
    2024 - Present
  • PRIMAThyC: PRofiling Immune cells and tumor-associated Macrophages in Anaplastic THYroid Carcinoma Agence Nationale de la Recherche
    2022 - 2026
  • PRIMAThyCCIO: PRofiling IMmune cells in Anaplastic Thyroid CarCInOma American Thyroid Association
    2021 - 2023
  • PRODIGE 69 - FOLFIRINEC Institut National Du Cancer
    2018 - Present
  • Reprogramming somatic cells with RET mutation into pluripotency: generation of medullary thyroid carcinoma stem cells. Inserm
    2012 - 2015

Publications

Publications are unavailable.